| aspsirna0041 |
GAGAUGGGGACAGUACUUC
CUCUACCCCUGUCAUGAAG |
70 |
28 |
42 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0042 |
GAGAUGGGGACAGUAAUUC
CUCUACCCCUGUCAUUAAG |
70 |
22 |
48 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0043 |
GGACAGUACUUCAACGCUA
CCUGUCAUGAAGUUGCGAU |
94 |
50 |
44 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0044 |
GGACAGUAAUUCAACGCUA
CCUGUCAUUAAGUUGCGAU |
50 |
92 |
-42 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0045 |
GGACAGUACAUCAACGCUA
CCUGUCAUGUAGUUGCGAU |
90 |
60 |
30 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0046 |
GGACAGUAAGUCAACGCUA
CCUGUCAUUCAGUUGCGAU |
55 |
82 |
-27 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0047 |
GCCUGCUCCCUCAUCUACU
CGGACGAGGGAGUAGAUGA |
90 |
70 |
20 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0048 |
GCCUGCUCCCUCAUCCACU
CGGACGAGGGAGUAGGUGA |
52 |
90 |
-38 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0049 |
UCCCUCAUCUACUGUGUGC
AGGGAGUAGAUGACACACG |
70 |
0 |
70 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0050 |
UCCCUCAUCCACUGUGUGC
AGGGAGUAGGUGACACACG |
22 |
70 |
-48 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0051 |
AUCUACUGUGUGCACUUCA
UAGAUGACACACGUGAAGU |
78 |
35 |
43 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0052 |
AUCCACUGUGUGCACUUCA
UAGGUGACACACGUGAAGU |
60 |
82 |
-22 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0053 |
GUUUGAGCUGAUGUAUGUG
CAAACUCGACUACAUACAC |
90 |
20 |
70 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0054 |
GUUUGAGCUAAUGUAUGUG
CAAACUCGAUUACAUACAC |
34 |
23 |
11 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0055 |
GUUUGAGCCGAUGUAUGUG
CAAACUCGGCUACAUACAC |
32 |
30 |
2 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0056 |
GUUUGAGCCAAUGUAUGUG
CAAACUCGGUUACAUACAC |
0 |
22 |
-22 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0057 |
GCUGAUGUAUGUGACGCUG
CGACUACAUACACUGCGAC |
92 |
58 |
34 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0058 |
GCUAAUGUAUGUGACGCUG
CGAUUACAUACACUGCGAC |
92 |
58 |
34 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19289118 |
| aspsirna0340 |
GAGUGAUGCAGAAGAAGGG
CUCACUACGUCUUCUUCCC |
85 |
10 |
75 |
Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) |
Sialuria |
|
18653764 |
| aspsirna0343 |
AAGAGGAGGAG---GCCGACGCCC
UUCUCCUCCUC---CGGCUGCGGG |
83 |
10 |
73 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19094060 |
| aspsirna0344 |
GAAGAGGAGGAG---GCCGACGCC
CUUCUCCUCCUC---CGGCUGCGG |
79 |
0 |
79 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19094060 |
| aspsirna0345 |
GACGAGGAAGAGGAGGAG---GCC
CUGCUCCUUCUCCUCCUC---CGG |
68 |
0 |
68 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19094060 |
| aspsirna0346 |
GAGGAAGAGGAGGAG---GCCGAC
CUCCUUCUCCUCCUC---CGGCUG |
74 |
72 |
2 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19094060 |
| aspsirna0348 |
UUCCAGCUGGGAUACCUGG
AAGGUCGACCCUAUGGACC |
74 |
76 |
-2 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0349 |
GUUCCAGCUGGGAUACCUG
CAAGGUCGACCCUAUGGAC |
50 |
58 |
-8 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0350 |
AGUUCCAGCUGGGAUACCU
UCAAGGUCGACCCUAUGGA |
24 |
0 |
24 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0351 |
AAGUUCCAGCUGGGAUACC
UUCAAGGUCGACCCUAUGG |
45 |
0 |
45 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0352 |
AAAGUUCCAGCUGGGAUAC
UUUCAAGGUCGACCCUAUG |
54 |
67 |
-13 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0353 |
CAAAGUUCCAGCUGGGAUA
GUUUCAAGGUCGACCCUAU |
39 |
0 |
39 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0354 |
UCAAAGUUCCAGCUGGGAU
AGUUUCAAGGUCGACCCUA |
10 |
5 |
5 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0355 |
AUCAAAGUUCCAGCUGGGA
UAGUUUCAAGGUCGACCCU |
82 |
0 |
82 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0356 |
UAUCAAAGUUCCAGCUGGG
AUAGUUUCAAGGUCGACCC |
79 |
0 |
79 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0357 |
GUAUCAAAGUUCCAGCUGG
CAUAGUUUCAAGGUCGACC |
90 |
10 |
80 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0358 |
GGUAUCAAAGUUCCAGCUG
CCAUAGUUUCAAGGUCGAC |
75 |
2 |
73 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0359 |
AGGUAUCAAAGUUCCAGCU
UCCAUAGUUUCAAGGUCGA |
80 |
5 |
75 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0360 |
CAGGUAUCAAAGUUCCAGC
GUCCAUAGUUUCAAGGUCG |
15 |
12 |
3 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0361 |
CCAGGUAUCAAAGUUCCAG
GGUCCAUAGUUUCAAGGUC |
3 |
3 |
0 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0362 |
UCCAGGUAUCAAAGUUCCA
AGGUCCAUAGUUUCAAGGU |
22 |
0 |
22 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0363 |
CUCCAGGUAUCAAAGUUCC
GAGGUCCAUAGUUUCAAGG |
20 |
4 |
16 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0364 |
CCUCCAGGUAUCAAAGUUC
GGAGGUCCAUAGUUUCAAG |
60 |
13 |
47 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0365 |
ACCUCCAGGUAUCAAAGUU
UGGAGGUCCAUAGUUUCAA |
55 |
14 |
41 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0366 |
GACCUCCAGGUAUCAAAGU
CUGGAGGUCCAUAGUUUCA |
86 |
62 |
24 |
Collagen, type III, alpha 1 (COL3A1) |
Vascular Ehlers-Danlos Syndrome (vEDs) |
|
22038052 |
| aspsirna0657 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
30 |
20 |
10 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0658 |
GUCUGUUACUAAGUGUGCC
CAGACAAUGAUUCACACGG |
50 |
10 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0659 |
AACAGUAGCAACAGCUGC
UUGUCAUCGUUGUCGACG |
20 |
15 |
5 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0660 |
CAGCAGCAGCAGCAGUAGC
GUCGUCGUCGUCGUCAUCG |
20 |
13 |
7 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0661 |
CAGUAGCAGCAGCAGCAGC
GUCAUCGUCGUCGUCGUCG |
34 |
20 |
14 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0662 |
CAGCAGCAGUUGCAGCAGC
GUCGUCGUCAACGUCGUCG |
58 |
22 |
36 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0663 |
AAGUCCUUCCAGCAGCUGC
UUCAGGAAGGUCGUCGACG |
43 |
10 |
33 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0664 |
AAGUCCUUCCAGCUGCAGC
UUCAGGAAGGUCGACGUCG |
5 |
11 |
-6 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0665 |
AAGUCCUUCCUGCAGCAGC
UUCAGGAAGGACGUCGUCG |
25 |
13 |
12 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0666 |
AAGUCCUUCUAGCAGCAGC
UUCAGGAAGAUCGUCGUCG |
82 |
18 |
64 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0667 |
AAGUCCAUCCAGCAGCAGC
UUCAGGUAGGUCGUCGUCG |
82 |
5 |
77 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0668 |
AAGACCUUCCAGCAGCAGC
UUCUGGAAGGUCGUCGUCG |
52 |
48 |
4 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0669 |
AAGUCCUUCCAGCAGCAGC
UUCAGGAAGGUCGUCGUCG |
40 |
25 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
23042244 |
| aspsirna0670 |
CAGCAGCAACAGCAGCAGCAGC
GUCGUCGUUGUCGUCGUCGUCG |
40 |
20 |
20 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0671 |
CAGCAGCAGAAGCAGCAGCAGC
GUCGUCGUCUUCGUCGUCGUCG |
10 |
Lowest effective |
Moderate discrimination |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0672 |
CAGAAGCAGCAGCAGCAGCAGC
GUCUUCGUCGUCGUCGUCGUCG |
50 |
Moderately effective |
discriminative |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0673 |
CAGCUGCAGCAGCAGCAGCAGC
GUCGACGUCGUCGUCGUCGUCG |
20 |
0 |
20 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0674 |
CAGCAACAGCAGCAGCAGCAGC
GUCGUUGUCGUCGUCGUCGUCG |
38 |
12 |
26 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0675 |
CAGCAGAAGCAGCAGCAGCAGC
GUCGUCUUCGUCGUCGUCGUCG |
78 |
38 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0676 |
CAGCAGCUGCAGCAGCAGCAGC
GUCGUCGACGUCGUCGUCGUCG |
70 |
30 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0677 |
CAGCAGCAUCAGCAGCAGCAGC
GUCGUCGUAGUCGUCGUCGUCG |
20 |
5 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0678 |
CAGCAGCAGUAGCAGCAGCAGC
GUCGUCGUCAUCGUCGUCGUCG |
46 |
40 |
6 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0679 |
CAGCAGCAGCUGCAGCAGCAGC
GUCGUCGUCGACGUCGUCGUCG |
35 |
20 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0680 |
CAGCAGCAGCAACAGCAGCAGC
GUCGUCGUCGUUGUCGUCGUCG |
62 |
50 |
12 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0681 |
CAGCAGCAGCAGAAGCAGCAGC
GUCGUCGUCGUCUUCGUCGUCG |
57 |
40 |
17 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0682 |
CAGCAGCAGCAGCAGAAGCAGC
GUCGUCGUCGUCGUCUUCGUCG |
50 |
30 |
20 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0683 |
CAGCAGCAAAAGCAGCAGCAGC
GUCGUCGUUUUCGUCGUCGUCG |
64 |
27 |
37 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0684 |
CAGCAGCAAAUGCAGCAGCAGC
GUCGUCGUUUACGUCGUCGUCG |
47 |
22 |
25 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0685 |
CAGCAGCUAAUGCAGCAGCAGC
GUCGUCGAUUACGUCGUCGUCG |
35 |
30 |
5 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0686 |
CAGAAGCAGAAGCAGAAGCAGC
GUCUUCGUCUUCGUCUUCGUCG |
82 |
20 |
62 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0687 |
CAACAGCUGCAGAAGCUGCAGC
GUUGUCGACGUCUUCGACGUCG |
60 |
10 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22939619 |
| aspsirna0688 |
GCAGCAGCAGCGGGACCUA
CGUCGUCGUCGCCCUGGAU |
80 |
40 |
40 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0689 |
GCAGCAGCAGCGGGACCUC
CGUCGUCGUCGCCCUGGAU |
86 |
15 |
71 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0690 |
GCAGCAGCAGCGGGACCUA
CGUCGUCGUCGCCCUGGAU |
45 |
85 |
-40 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0691 |
GCAGCAGCAGCGGGACCUAUCAGGACA
CGUCGUCGUCGCCCUGGAUAGUCCUGU |
70 |
24 |
46 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0692 |
CAGCAGCAGCGGGACCUAG
GUCGUCGUCGCCCUGGAUA |
62 |
40 |
22 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0693 |
GCAGCAGCGGGACCUAUCA
CGUCGUCGCCCUGGAUAGU |
70 |
50 |
20 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0694 |
CAGCGGGACCUAUCAGGAA
GUCGCCCUGGAUAGUCCUG |
70 |
38 |
32 |
Ataxin-3 (ATXN3) |
Spino Cerebellar Ataxia type-3 (SCA-3) |
|
22397573 |
| aspsirna0695 |
CAGUGGCUCACCAGAUUAC
GUCACCGAGUGGUCUAAUG |
72 |
30 |
42 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0696 |
CAGUGGCUCCCCUGAUUAC
GUCACCGAGGGGACUAAUG |
76 |
20 |
56 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0697 |
CAGUGGCUCCCUACAUUAC
GUCACCGAGGGAUGUAAUG |
80 |
16 |
64 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0698 |
CAGUGGCUCCCCAAUUUAC
GUCACCGAGGGGUUAAAUG |
85 |
40 |
45 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0699 |
AGAUUUGGACCUGGCAGUC
UCUAAACCUGGACCGUCAG |
75 |
25 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0700 |
AGACUUGGACCAGGCAGUC
UCUGAACCUGGUCCGUCAG |
10 |
48 |
-38 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
22397573 |
| aspsirna0701 |
CCAAGAAAGCCGAGAGCAU
GGUUCUUUCGGCUCUCGUC |
0 |
24 |
-24 |
Ataxin-1 (ATXN1) |
Spino Cerebellar Ataxia type-1 (SCA-1) |
|
22397573 |
| aspsirna0702 |
CAAGAAAGCCGAGAGCAGA
GUUCUUUCGGCUCUCGUCG |
0 |
20 |
-20 |
Ataxin-1 (ATXN1) |
Spino Cerebellar Ataxia type-1 (SCA-1) |
|
22397573 |
| aspsirna0703 |
AAGAAAGCCGAGAGCAGUA
UUCUUUCGGCUCUCGUCGG |
58 |
32 |
26 |
Ataxin-1 (ATXN1) |
Spino Cerebellar Ataxia type-1 (SCA-1) |
|
22397573 |
| aspsirna0704 |
AGCCGAGAGCAGCCGGCUU
UCGGCUCUCGUCGGCCGAC |
47 |
78 |
-31 |
Ataxin-1 (ATXN1) |
Spino Cerebellar Ataxia type-1 (SCA-1) |
|
22397573 |
| aspsirna0775 |
CAGCAGCAGCAGCAGUAGC
GUCGUCGUCGUCGUCAUCG |
45 |
20 |
25 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0776 |
CAGCAGCAGCAGCAUCAGC
GUCGUCGUCGUCGUAGUCG |
15 |
10 |
5 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0777 |
CAGCAGCAGCAGCUGCAGC
GUCGUCGUCGUCGACGUCG |
20 |
90 |
-70 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0778 |
CAGCAGCAGCAGUAGCAGC
GUCGUCGUCGUCAUCGUCG |
30 |
30 |
0 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0779 |
CAGCAGCAGCAUCAGCAGC
GUCGUCGUCGUAGUCGUCG |
66 |
20 |
46 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0780 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
60 |
20 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0781 |
CAGCAGCAGUAGCAGCAGC
GUCGUCGUCAUCGUCGUCG |
50 |
40 |
10 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0782 |
CAGCAGCAGAAGCAGCAGC
GUCGUCGUCUUCGUCGUCG |
30 |
35 |
-5 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0783 |
CAGCAGCAUCAGCAGCAGC
GUCGUCGUAGUCGUCGUCG |
48 |
52 |
-4 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0784 |
CAGCAGCUGCAGCAGCAGC
GUCGUCGACGUCGUCGUCG |
88 |
55 |
33 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0785 |
CAGCAGUAGCAGCAGCAGC
GUCGUCAUCGUCGUCGUCG |
87 |
80 |
7 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0786 |
CAGUAGCAGCAGCAGCAGC
GUCAUCGUCGUCGUCGUCG |
93 |
30 |
63 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0787 |
CAGCAGCAGUUGCAGCAGC
GUCGUCGUCAACGUCGUCG |
60 |
20 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0788 |
CAGCAGCAUUUGCAGCAGC
GUCGUCGUAAACGUCGUCG |
80 |
30 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0789 |
CAGCAGCAUUUUCAGCAGC
GUCGUCGUAAAAGUCGUCG |
78 |
25 |
53 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0790 |
CAGUAGCAGUAGCAGUAGC
GUCAUCGUCAUCGUCAUCG |
70 |
30 |
40 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0791 |
CAACAGUAGCAACAGCUGC
GUUGUCAUCGUUGUCGACG |
88 |
25 |
63 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0792 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
85 |
60 |
25 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0793 |
CAGCAGCAGUAGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
80 |
70 |
10 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0794 |
CAGCAGCAGUUGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
79 |
26 |
53 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0795 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCGACGUCGUCG |
85 |
22 |
63 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0796 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCAUCGUCGUCG |
62 |
17 |
45 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0797 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCUUCGUCGUCG |
90 |
15 |
75 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0798 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUAGUCGUCGUCG |
70 |
40 |
30 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0799 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCAACGUCGUCG |
78 |
20 |
58 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0800 |
GCAGCAGCAGCAGCAGCAG
CGUCGUCGUAGUCGUCGUC |
84 |
15 |
69 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0801 |
AGCAGCAGCAGCAGCAGCA
UCGUCGUCGACGUCGUCGU |
69 |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21095568 |
| aspsirna0874 |
GUCCCGGCAGGUGGUGGAGC
CAGGGCCGUCCACCACCUCG |
70 |
10 |
60 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
18776243 |
| aspsirna0875 |
GACCCGGCAGGUGGUGGAGCA
CUGGGCCGUCCACCACCUCGU |
80 |
20 |
60 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
18776243 |
| aspsirna0895 |
AGCAGAGUGGCUGAG---AUGA
UCGUCUCACCGACUC---UACU |
46 |
5 |
41 |
Torsin family 1, member A (TOR1A) |
Early onset torsion dystonia (DYT1) |
|
18258738 |
| aspsirna0896 |
GCAGAGUGGCUGAG---AUGAC
CGUCUCACCGACUC---UACUG |
67 |
52 |
15 |
Torsin family 1, member A (TOR1A) |
Early onset torsion dystonia (DYT1) |
|
18258738 |
| aspsirna0897 |
AAGCAGAGUGGCUGAGGAG
UUCGUCUCACCGACUCCUC |
74 |
70 |
4 |
Torsin family 1, member A (TOR1A) |
Early onset torsion dystonia (DYT1) |
|
18258738 |
| aspsirna0898 |
AGCAGAGUGGCUGAGGAGA
UCGUCUCACCGACUCCUCU |
56 |
34 |
22 |
Torsin family 1, member A (TOR1A) |
Early onset torsion dystonia (DYT1) |
|
18258738 |
| aspsirna0971 |
CAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUC |
75 |
60 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0972 |
CAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUC |
50 |
39 |
11 |
Ataxin-1 (ATXN1) |
Spino Cerebellar Ataxia type-1 (SCA-1) |
|
21427085 |
| aspsirna0973 |
CAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUC |
70 |
30 |
40 |
Ataxin-3 (ATXN3) |
Parkinsons disease (PD) |
|
21427085 |
| aspsirna0974 |
GUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAG |
68 |
15 |
53 |
Ribosomal protein L14 (RPL14) |
Neurological disorder |
|
21427085 |
| aspsirna0975 |
GUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAG |
65 |
20 |
45 |
Low density lipoprotein receptor-related protein 8 (LRP8) |
Neurological disorder |
|
21427085 |
| aspsirna0976 |
GUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAG |
70 |
52 |
18 |
EIF2AK (EIF2AK1) |
Neurological disorder |
|
21427085 |
| aspsirna0977 |
CAGCAGCAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUCGUCGUC |
75 |
60 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0978 |
CAGCAGCAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUCGUCGUC |
56 |
39 |
17 |
Ataxin-1 (ATXN1) |
Neurological disorder |
|
21427085 |
| aspsirna0979 |
CAGCAGCAGCAGCAGCAGCAGCAGCAG
GUCGUCGUCGUCGUCGUCGUCGUCGUC |
78 |
30 |
48 |
Ataxin-3 (ATXN3) |
Parkinsons disease (PD) |
|
21427085 |
| aspsirna0980 |
GUCGUCGUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAGCAGCAG |
63 |
15 |
48 |
Ribosomal protein L14 (RPL14) |
Neurological disorder |
|
21427085 |
| aspsirna0981 |
GUCGUCGUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAGCAGCAG |
60 |
20 |
40 |
Low density lipoprotein receptor-related protein 8 (LRP8) |
Neurological disorder |
|
21427085 |
| aspsirna0982 |
GUCGUCGUCGUCGUCGUCGUCGUCGUC
CAGCAGCAGCAGCAGCAGCAGCAGCAG |
70 |
50 |
20 |
EIF2AK (EIF2AK1) |
Neurological disorder |
|
21427085 |
| aspsirna0983 |
CAGCAGCAGCAGUAGCAGCAG
GUCGUCGUCGUCAUCGUCGUC |
75 |
20 |
55 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0984 |
CAGCAGCAGCAGCAGUAGCAG
GUCGUCGUCGUCGUCAUCGUC |
60 |
23 |
37 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0985 |
CAGCAGCAGCAGUAGUAGCAG
GUCGUCGUCGUCAUCAUCGUC |
78 |
20 |
58 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0986 |
UAGCAGCAGCAGCAGCAGUAG
AUCGUCGUCGUCGUCGUCAUC |
60 |
45 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0991 |
CAGCAGCAGCAGCAGU
GUCGUCGUCGUCGUCAUCGUC |
60 |
25 |
35 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0992 |
CAGCAGCAGCAGUAGU
GUCGUCGUCGUCAUCAUCGUC |
78 |
25 |
53 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0993 |
CAGCAGCAGCAGCAGUA
GUCGUCGUCGUCGUCAUCGUC |
60 |
25 |
35 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0994 |
CAGCAGCAGCAGUAGUA
GUCGUCGUCGUCAUCAUCGUC |
78 |
25 |
53 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0995 |
CAGCAGCAGCAGCAGU
GUCGUCGUCGUCGUCAUCGUC |
60 |
25 |
35 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0996 |
CAGCAGCAGCAGUAGU
GUCGUCGUCGUCAUCAUCGUC |
70 |
25 |
45 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0997 |
CAGCAGCAGCAGCAGUA
GUCGUCGUCGUCGUCAUCGUC |
60 |
30 |
30 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna0998 |
CAGCAGCAGCAGUAGUA
GUCGUCGUCGUCAUCAUCGUC |
78 |
20 |
58 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
21427085 |
| aspsirna1892 |
CUGGUGAAGCUUGUCGUCC
GACCACUUCGAACAGCAGG |
65 |
15 |
50 |
Collagen type I alpha 1 (COL1A1) |
Osteogenesis Imperfecta (OI) |
|
24022296 |
| aspsirna1893 |
UGGUGAAGCUUGUCGUCCC
ACCACUUCGAACAGCAGGG |
58 |
1 |
57 |
Collagen type I alpha 1 (COL1A1) |
Osteogenesis Imperfecta (OI) |
|
24022296 |
| aspsirna1894 |
CUGGUGAAGCUUGUCGUCC
GACCACUUCGAACAGCAGG |
60 |
15 |
45 |
Collagen type I alpha 1 (COL1A1) |
Osteogenesis Imperfecta (OI) |
|
24022296 |
| aspsirna1895 |
UGGUGAAGCUUGUCGUCCC
ACCACUUCGAACAGCAGGG |
60 |
11 |
49 |
Collagen type I alpha 1 (COL1A1) |
Osteogenesis Imperfecta (OI) |
|
24022296 |
| aspsirna2199 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
NA |
NA |
NA |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2200 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
50 |
25 |
25 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2201 |
CAGCAGCAUUUUCAGCAGC
GUCGUCGUAAAAGUCGUCG |
80 |
30 |
50 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2202 |
CAGCUGCAGCUGCAGCAGC
GUCGACGUCGACGUCGUCG |
60 |
40 |
20 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2203 |
CAGGAGCAGCUGCAGCAGC
GUCCUCGUCGACGUCGUCG |
70 |
33 |
37 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2204 |
AACAGCAGCAGCUGCAGCAGC
UUGUCGUCGUCGACGUCGUCG |
80 |
20 |
60 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2205 |
AACAGCAGCAGUUGCAGCAGC
UUGUCGUCGUCAACGUCGUCG |
83 |
15 |
68 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2206 |
AACAGCAGCAUUUGCAGCAGC
UUGUCGUCGUAAACGUCGUCG |
78 |
5 |
73 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2207 |
AACAGCAGCAUUUUCAGCAGC
UUGUCGUCGUAAAAGUCGUCG |
90 |
10 |
80 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2208 |
AAGCAGCAUUUGCAGCAG
UUCGUCGUAAACGUCGUC |
72 |
15 |
57 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2209 |
AAAGCAGCAGUUUCAGCAGCA
UUUCGUCGUCAAAGUCGUCGU |
81 |
35 |
46 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2210 |
AAAGCAGCAGUUUUAGCAGCA
UUUCGUCGUCAAAAUCGUCGU |
89 |
50 |
39 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2211 |
AAAUGACGACGCUGGUAUAGC
UUUACUGCUGCGACCAUAUCG |
60 |
40 |
20 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2212 |
AACAGCAGCUGCAGCAGC
UUGUCGUCGUCGUCGUCG |
93 |
10 |
83 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2213 |
CAGCAGCAGUAGCAGCAGC
GUCGUCGUCUUCGUCGUCG |
91 |
23 |
68 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2214 |
CAGCAGCAUCAGCAGCAGC
GUCGUCGUUGUCGUCGUCG |
96 |
43 |
53 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2215 |
AACAGCAGCAGCUGCAGCAGC
UUGUCGUCGUCGUCGUCGUCG |
98 |
40 |
58 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2216 |
CAGCAGCAGUAGCAGCAGC
GUCGUCGUCUUCGUCGUCG |
89 |
13 |
76 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2217 |
CAGCAGCAUCAGCAGCAGC
GUCGUCGUUGUCGUCGUCG |
98 |
34 |
64 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2218 |
CAGCAGCAUCUUCAGCAGC
GUCGUCGUUGUUGUCGUCG |
75 |
28 |
47 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2219 |
CAGCAGCAGUUUCAGCAGC
GUCGUCGUCUUUGUCGUCG |
69 |
38 |
31 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2220 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
65 |
8 |
57 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2221 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
97 |
10 |
87 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2222 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
60 |
13 |
47 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2223 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
58 |
23 |
35 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2224 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
67 |
30 |
37 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2225 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
80 |
30 |
50 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2226 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
90 |
70 |
20 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2227 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
70 |
33 |
37 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2228 |
CAGCAGCAGCAGCAGCAGC
GUCGUCGUCGUCGUCGUCG |
65 |
25 |
40 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2229 |
UUCAGCAGCAGCUGCAGCAGU
AAGUCGUCGUCGACGUCGUCU |
96 |
30 |
66 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2230 |
UUCAGCAGCAGCAGCAGUAGU
AAGUCGUCGUCGUCGUCAUCU |
48 |
20 |
28 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2231 |
UUCAGCAGCAGCAGCAUCAGU
AAGUCGUCGUCGUCGUAGUCU |
60 |
10 |
50 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2232 |
UUCAGCAGCAGCAGCUGCAGU
AAGUCGUCGUCGUCGACGUCU |
30 |
10 |
20 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2233 |
UUCAGCAGCAGCAGUAGCAGU
AAGUCGUCGUCGUCAUCGUCU |
50 |
13 |
37 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2234 |
UUCAGCAGCAGCAUCAGCAGU
AAGUCGUCGUCGUAGUCGUCU |
70 |
35 |
35 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2235 |
UUCAGCAGCAGCUGCAGCAGU
AAGUCGUCGUCGACGUCGUCU |
94 |
24 |
70 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2236 |
UUCAGCAGCAGUAGCAGCAGU
AAGUCGUCGUCAUCGUCGUCU |
75 |
34 |
41 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2237 |
UUCAGCAGCAUCAGCAGCAGU
AAGUCGUCGUAGUCGUCGUCU |
69 |
30 |
39 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2238 |
UUCAGCAGCUGCAGCAGCAGU
AAGUCGUCGACGUCGUCGUCU |
76 |
26 |
50 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2239 |
UUCAGUAGCAGCAGCAGCAGU
AAGUCAUCGUCGUCGUCGUCU |
80 |
18 |
62 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2240 |
UUCAGCAGCAGUUGCAGCAGU
AAGUCGUCGUCAACGUCGUCU |
67 |
25 |
42 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2241 |
UUCAGCAGCAUUUGCAGCAGU
AAGUCGUCGUAAACGUCGUCU |
90 |
25 |
65 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2242 |
UUCAGCAGCAUUUUCAGCAGU
AAGUCGUCGUAAAAGUCGUCU |
50 |
18 |
32 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2243 |
UUCAGCAGCAUCUGCAGCAGU
AAGUCGUCGUAGACGUCGUCU |
80 |
45 |
35 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2244 |
UUCAGCAGUAGCUGCAGCAGU
AAGUCGUCAUCGACGUCGUCU |
60 |
10 |
50 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2245 |
UUCAGCAUCAGCUGCAGCAGU
AAGUCGUAGUCGACGUCGUCU |
90 |
60 |
30 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2246 |
UUCAGCUGCAGCUGCAGCAGU
AAGUCGACGUCGACGUCGUCU |
85 |
30 |
55 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2247 |
UUCAGCAGCAGCUGCAGCAGU
AAGUCGUCGUCGACGUCGUCU |
87 |
40 |
47 |
Atrophin-1 (ATN-1) |
Dentatorubral-pallidoluysian atrophy (DRPLA) |
|
24981774 |
| aspsirna2993 |
CACUAGUAGUAAGUAUAAU
GUGAUCAUCAUUCAUAUUA |
50 |
15 |
35 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
| aspsirna2994 |
UAUGUGGAUACAAAUUCUC
AUACACCUAUGUUUAAGAG |
30 |
13 |
17 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
| aspsirna3027 |
CAGCAGCAGCAGCAGUAGC
GUCGUCGUCGUCGUCAUCG |
60 |
40 |
20 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3028 |
CAGCAGCAGCAGCAUCAGC
GUCGUCGUCGUCGUAGUCG |
60 |
50 |
10 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3029 |
CAGCAGCAGCAGCUGCAGC
GUCGUCGUCGUCGACGUCG |
35 |
30 |
5 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3030 |
CAGCAGCAGCAGUAGCAGC
GUCGUCGUCGUCAUCGUCG |
80 |
70 |
10 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3031 |
CAGCAGCAGCAUCAGCAGC
GUCGUCGUCGUAGUCGUCG |
70 |
30 |
40 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3032 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
80 |
25 |
55 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3033 |
CAGCAGCAGUAGCAGCAGC
GUCGUCGUCAUCGUCGUCG |
80 |
40 |
40 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3034 |
CAGCAGCAGAAGCAGCAGC
GUCGUCGUCUUCGUCGUCG |
87 |
25 |
62 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3035 |
CAGCAGCAGUUGCAGCAGC
GUCGUCGUCAACGUCGUCG |
90 |
20 |
70 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3036 |
CAGCAGCAUUUGCAGCAGC
GUCGUCGUAAACGUCGUCG |
90 |
20 |
70 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3037 |
CAGCAGCAUUUUCAGCAGC
GUCGUCGUAAAAGUCGUCG |
80 |
30 |
50 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3038 |
CAGCAGCAUCAGCAGCAGC
GUCGUCGUAGUCGUCGUCG |
85 |
30 |
55 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3039 |
CAGCAGCUGCAGCAGCAGC
GUCGUCGACGUCGUCGUCG |
90 |
50 |
40 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3040 |
CAGCAGUAGCAGCAGCAGC
GUCGUCAUCGUCGUCGUCG |
70 |
60 |
10 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3041 |
CAGUAGCAGCAGCAGCAGC
GUCAUCGUCGUCGUCGUCG |
80 |
60 |
20 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3042 |
CAACAGUAGCAACAGCUGC
GUUGUCAUCGUUGUCGACG |
87 |
78 |
9 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3043 |
CAGCAGCAGCUGCAGCAGC
GUCGUCGUCGACGUCGUCG |
78 |
20 |
58 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3044 |
CAGCAGCAGUUGCAGCAGC
GUCGUCGUCAACGUCGUCG |
85 |
20 |
65 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3045 |
CAGCAGCAUUUGCAGCAGC
GUCGUCGUAAACGUCGUCG |
85 |
30 |
55 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
| aspsirna3046 |
CAGCAGCAUUUUCAGCAGC
GUCGUCGUAAAAGUCGUCG |
75 |
35 |
40 |
Ataxin-3 (ATXN3) |
Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
|
21294677 |
